These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31268949)

  • 1. Comparison of clinical manifestations and outcomes of noncirrhotic and cirrhotic hepatocellular carcinoma patients with chronic hepatitis B.
    Hwan YJ; Shin J; Jin YJ; Lee JW
    Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):66-73. PubMed ID: 31268949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between hepatocellular carcinoma and hepatitis B virus infection in patients with and without cirrhosis.
    Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
    Ann Surg Oncol; 2014 Feb; 21(2):458-65. PubMed ID: 24132624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
    van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis.
    Poon RT; Fan ST; Lo CM; Liu CL; Ng IO; Wong J
    J Clin Oncol; 2000 Mar; 18(5):1094-101. PubMed ID: 10694562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients.
    Trevisani F; D'Intino PE; Caraceni P; Pizzo M; Stefanini GF; Mazziotti A; Grazi GL; Gozzetti G; Gasbarrini G; Bernardi M
    Cancer; 1995 May; 75(9):2220-32. PubMed ID: 7536121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma incidence in noncirrhotic patients with chronic hepatitis B and patients with cirrhosis of all etiologies.
    Do AL; Wong CR; Nguyen LH; Nguyen VG; Trinh H; Nguyen MH
    J Clin Gastroenterol; 2014 Aug; 48(7):644-9. PubMed ID: 24201999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Portal Vein Thrombosis Predicts Concomitant Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients.
    Khoury T; Massarwa M; Hazou W; Daher S; Hakimian D; Benson AA; Ashqar T; Mahamid M; Yaari S
    J Gastrointest Cancer; 2019 Dec; 50(4):759-762. PubMed ID: 30043228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma arising in noncirrhotic and highly cirrhotic livers: a comparative study of histopathology and frequency of hepatitis B markers.
    Okuda K; Nakashima T; Sakamoto K; Ikari T; Hidaka H; Kubo Y; Sakuma K; Motoike Y; Okuda H; Obata H
    Cancer; 1982 Feb; 49(3):450-5. PubMed ID: 6277447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection.
    Lee HW; Choi GH; Kim DY; Park YN; Kim KS; Choi JS; Ahn SH; Han KH
    Oncology; 2017; 93(4):224-232. PubMed ID: 28571030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stratification of hepatocellular carcinoma risk through modified FIB-4 index in chronic hepatitis B patients on entecavir therapy.
    Wang HW; Lai HC; Hu TH; Su WP; Lu SN; Lin CH; Hung CH; Chuang PH; Wang JH; Lee MH; Chen CH; Peng CY
    J Gastroenterol Hepatol; 2019 Feb; 34(2):442-449. PubMed ID: 29968933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective viral suppression is necessary to reduce hepatocellular carcinoma development in cirrhotic patients with chronic hepatitis B: Results of a 10-year follow up.
    Zhang W; Wang X; Wang Y; Zhao X; Duan W; Wang Q; Wu X; Kong Y; Ma H; You H; Ou X; Jia J
    Medicine (Baltimore); 2017 Nov; 96(44):e8454. PubMed ID: 29095292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis.
    Techathuvanan K; Srisajjakul S; Pongpaibul A; Limsrichamrern S; Charatcharoenwitthaya P; Chainuvati S; Tanwandee T; Chotiyaputta W
    J Med Assoc Thai; 2015 Apr; 98(4):334-42. PubMed ID: 25958707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Incidence of Cirrhotic and Noncirrhotic Hepatocellular Carcinoma in the United States.
    Donica WRF; Stephens KR; Martin RCG; Philips P; Scoggins CR; Boone S; McMasters KM; Egger ME
    J Surg Res; 2024 Oct; 302():641-647. PubMed ID: 39197286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of hepatitis B-associated hepatocellular carcinoma in Victoria.
    Sinclair M; Roberts S; Kemp W; Knight V; Dev A; Gow P; Philpott H; Kronborg I; Arachchi NJ; Bell S; Lim L; Gorelik A; Nicoll A;
    Intern Med J; 2013 May; 43(5):501-6. PubMed ID: 23279328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of survival outcomes of alcohol-related hepatocellular carcinoma with or without liver cirrhosis; a ten-year experience.
    Shin J; Yu JH; Jin YJ; Chae MH; Yoon CH; Lee JW
    Medicine (Baltimore); 2019 Nov; 98(47):e18020. PubMed ID: 31764818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile and value of FIB-4 in patients with dual chronic hepatitis C and B.
    Liu CJ; Tseng TC; Yang WT; Su TH; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2019 Feb; 34(2):410-417. PubMed ID: 30151861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia.
    Paik N; Sinn DH; Lee JH; Oh IS; Kim JH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Liver Int; 2018 Jan; 38(1):68-75. PubMed ID: 28581248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior surveillance and antiviral treatment improve the prognosis of HCC developed in HBV patients in the West.
    Allaire M; El Hajj W; Brichler S; Diallo K; Fanica D; Blaise L; Nkontchou G; Grando V; Arbadi F; Nahon P; Ziol M; Nault JC; Ganne-Carrié N
    Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101436. PubMed ID: 32418851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy.
    Jiang XY; Huang B; Huang DP; Wei CS; Zhong WC; Peng DT; Huang FR; Tong GD
    World J Gastroenterol; 2021 Mar; 27(11):1101-1116. PubMed ID: 33776376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and Clinical Features of Hepatitis C Virus-associated Hepatocellular Carcinoma Patients without Liver Cirrhosis in Hepatitis B Virus-endemic Area.
    Shin J; Yu JH; Jin YJ; Lee JW
    J Liver Cancer; 2021 Mar; 21(1):34-44. PubMed ID: 37384274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.